Innate Pharma SA Noncurrent Assets
Innate Pharma SA (IPHA) had Noncurrent Assets of EUR 16.01 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:NoncurrentAssets · last filed 2026-04-01
- 2025-12-31: Noncurrent Assets 16.01M EUR.
- 2025-06-30: Noncurrent Assets 27.96M EUR.
- 2024-12-31: Noncurrent Assets 25.32M EUR.
- 2024-06-30: Noncurrent Assets 39.90M EUR.
| Period end | Noncurrent Assets | Noncurrent Assets as first filed |
|---|---|---|
| 2025-12-31 | 16.01M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 27.96M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 25.32M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 39.90M EUR 6-K · filed 2024-09-12 | |
| 2023-12-31 | 27.18M EUR 20-F · filed 2026-04-01 | 36.18M EUR 20-F · filed 2024-04-04 |
| 2023-06-30 | 54.59M EUR 6-K · filed 2023-09-14 | |
| 2022-12-31 | 59.47M EUR 20-F · filed 2025-04-30 | 68.03M EUR 20-F · filed 2023-04-06 |
| 2022-06-30 | 108.63M EUR 6-K · filed 2022-09-15 | |
| 2021-12-31 | 129.24M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 136.53M EUR 6-K · filed 2021-09-15 | |
| 2020-12-31 | 133.97M EUR 20-F · filed 2023-04-06 | |
| 2019-12-31 | 163.76M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 131.57M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 117.50M EUR 20-F · filed 2020-04-24 |